Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
鲁索替尼与最佳可用疗法治疗真性红细胞增多症的长期疗效和安全性(RESPONSE):一项3期研究的5年随访
期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(19)30207-8
Kiladjian, Jean-Jacques; Zachee, Pierre; Hino, Masayuki; Pane, Fabrizio; Masszi, Tamas; Harrison, Claire N; Mesa, Ruben; Miller, Carole B; Passamonti, Francesco; Durrant, Simon; Griesshammer, Martin; Kirito, Keita; Besses, Carlos; Moiraghi, Beatriz; Rumi, Elisa; Rosti, Vittorio; Blau, Igor Wolfgang; Francillard, Nathalie; Dong, Tuochuan; Wroclawska, Monika; Vannucchi, Alessandro M; Verstovsek, Srdan